Agios Pharmaceuticals, Inc. · NASDAQ:AGIO
Bellevue Group AG's stake in Agios Pharmaceuticals, Inc. fell below 5% (Schedule 13G/A)
Event Nov 19, 2025 · Filed Dec 5, 2025
Bellevue Group AG's stake in Agios Pharmaceuticals, Inc. fell below 5%, 0 shares, as a passive investor on Nov 19, 2025. Filed Dec 5, 2025 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Bellevue Group AG | 0% | 0 |
| Bellevue Asset Management AG | 0% | 0 |
Source
Related
- Agios Pharmaceuticals, Inc.
- Bellevue Group AG
- Agios Pharmaceuticals, Inc. shareholders
- Schedule 13G · Bellevue Group AG · Jul 7, 2025
- Form 4 · Gheuens Sarah · Aug 6, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 3, 2026
- Form 4 · Backstrom Jay T. · Jul 10, 2026
- Form 4 · Gheuens Sarah · Jul 2, 2026
- Schedule 13G · D. E. Shaw & Co., L.P. · Jul 2, 2026